Results 111 to 120 of about 36,179 (151)

Intermediate doses cytarabine after induction with CPX-351 for patients with secondary AML: safety and efficacy. [PDF]

Ann Hematol
Perrone S, Corbingi A, Vetro C, Palumbo FE, Minetto P, Riva C, Cicconi L, Vernarecci C, Lemoli RM, Pulsoni A, Guolo F.   +10 more
europepmc   +1 more source

Impact of Acute Lymphoblastic Leukemia Treatment on Left Ventricular Function Assessed in 2D and 3D Speckle Tracing Echocardiography-Preliminary Results. [PDF]

J Clin Med
Haponiuk-Skwarlińska J, Kamińska H, Albrecht K, Łaguna P, Werner B.   +4 more
europepmc   +1 more source

Evaluation of Efficacy, Safety, and Prognostic Value of Induction Chemotherapy in Patients with Acute Myeloid Leukemia: An Updated Meta-Analysis of a 5-Year Study. [PDF]

Int J Hematol Oncol Stem Cell Res
Komara IMAN, Suega K, Rena NMRA, Adnyana IWL.   +3 more
europepmc   +1 more source

Erythrocytes as carriers of anthracycline antibiotics

Терапевтический архив, 2008
A G Tikhonova, Iu G Aleksandrovich, T A Vuĭmo, E I Sinauridze, F I Ataullakhanov   +4 more
doaj  

Some of the next articles are maybe not open access.

Related searches:

Daunorubicin

Reactions Weekly, 2021
  +5 more sources

Daunorubicin

Reactions Weekly, 2010
Ines Mader, Patrizia Fürst-Weger, Robert Mader, Elisabeth Nogler-Semenitz, Sabine Wassertheurer   +4 more
openaire   +2 more sources

Daunorubicin

Reactions Weekly, 1992
  +4 more sources

DAUNORUBICIN

Reactions Weekly
Stephanie J. Phelps, Tracy M. Hagemann, Kelley R. Lee   +2 more
  +5 more sources

Daunorubicin

Reactions Weekly, 2009
  +4 more sources

Daunorubicin

Reactions Weekly, 2008
openaire   +2 more sources